Bahram B.
- Country
- France
- Department
- Ophtalmology
Research Overview
- Comparative Efficacy and Safety of Adalimumab Versus Mycophenolate Mofetil in Steroid-Dependent Non-Infectious Uveitis
- Efficacy and Safety Evaluation of Izokibep in Patients with Non-infectious Intermediate, Posterior, or Pan-uveitis: A Phase 2b Randomized Controlled Trial
- A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE MASKED, SHAM-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WITH UVEITIC MACULAR EDEMA
Data & Insights
Has run more than one trial at 14 of 61 partner sites.
Specializations
Ophthalmologic Conditions
This investigator specializes in treating complex ocular inflammatory conditions, with particular emphasis on uveitic macular edema and various forms of non-infectious uveitis.
- Intermediate Uveitis
- Posterior Uveitis
- Pan-uveitis
The research focus includes innovative therapeutic approaches for managing inflammation-related eye conditions.
Inflammatory Eye Disorders
The investigator concentrates on developing treatments for steroid-dependent inflammatory eye conditions, exploring both conventional and novel therapeutic approaches.
- Macular Edema Management
- Inflammatory Disease Control
- Ocular Immunotherapy
Expertise extends to intravitreal administration techniques and immunosuppressive therapies.
Therapeutic Applications
The investigator evaluates diverse treatment modalities including intravitreal therapeutics and systemic immunomodulators for ocular conditions.
- Novel Biological Therapies
- Immunosuppressive Treatments
- Long-term Disease Management
Focus includes comparative assessment of treatment efficacy in inflammatory eye disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.